Clinical Trial Update: Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of docetaxel, vinorelbine, and sargramostim in metastatic melanoma has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Vinorelbine (Vinorelbine)
• sargramostim (sargramostim)

Snippet

Sponsor: John P. Fruehauf | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2018-05-03